Literature DB >> 2988765

Histological types of carcinoma of the uterine cervix and the detectability of human papillomavirus DNA.

M Fukushima, T Okagaki, L B Twiggs, B A Clark, K R Zachow, R S Ostrow, A J Faras.   

Abstract

Using the Southern DNA hybridization technique, tissues from 17 cases of invasive carcinoma of the uterine cervix, including nine cases of squamous cell carcinoma, four cases of adenocarcinoma, one case of adenosquamous carcinoma, and three cases of undifferentiated carcinoma, were examined for the presence of human papillomavirus (HPV) DNA. None of the studied cases had histologically confirmed association of condyloma acuminatum or cervical intraepithelial neoplasia in the vicinity. HPV DNA was detected in two of 17 cases under low stringency conditions. One lesion was undifferentiated carcinoma, and another was squamous cell carcinoma. Hybridization under high stringency conditions with a variety of HPV DNA probes indicated the presence of HPV-16 in these two lesions. The other HPV-positive lesion was adenocarcinoma, demonstrating weak hybridizations with HPV-2 and HPV-16 DNA probes only under high stringency conditions. Altogether, three of 17 cases (17.6%) contained HPV DNA. This observation contrasts to the rate of HPV DNA present in 15 of 18 cases (83.3%) of the tissues of cervical intraepithelial neoplasia. Our data suggest that HPV was not consistently detected in invasive squamous cell carcinoma, despite the frequent association of HPV with its supposed precursor lesions of cervical intraepithelial neoplasia.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988765

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

Review 1.  The molecular biology of human papillomaviruses and the pathogenesis of genital papillomas and neoplasms.

Authors:  R S Ostrow; A J Faras
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  DNA probes for clinical applications. Patents and literature.

Authors:  R J Linhardt
Journal:  Appl Biochem Biotechnol       Date:  1986-06       Impact factor: 2.926

3.  Transforming activity of human papillomavirus type 16 DNA sequence in a cervical cancer.

Authors:  Y Tsunokawa; N Takebe; T Kasamatsu; M Terada; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

4.  A research for the relationship between human papillomavirus and human uterine cervical carcinoma. II. Molecular genetic and ultrastructural study on the transforming activity of recombinant retrovirus containing human papillomavirus type 16 subgenomic sequences.

Authors:  J Y Si; K Lee; W Zhang; R C Han; G X Song; L F Chen; W M Zhao; L P Jia; S Liu; Y Y Mai
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 5.  Human papillomaviruses: are we ready to type?

Authors:  A Roman; K H Fife
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

6.  Human papillomavirus sequences are not detectable by Southern blotting or general primer-mediated polymerase chain reaction in transitional cell tumours of the bladder.

Authors:  M A Knowles
Journal:  Urol Res       Date:  1992

Review 7.  Biologic response modifiers in gynecologic malignancies.

Authors:  J P Dutcher; S Wadler; P H Wiernik
Journal:  Yale J Biol Med       Date:  1988 Jul-Aug

8.  Prevalence of human papillomavirus types 16 and 18 in cervical carcinomas: a study by dot and Southern blot hybridization and the polymerase chain reaction.

Authors:  S H Low; T W Thong; T H Ho; Y S Lee; T Morita; M Singh; E H Yap; Y C Chan
Journal:  Jpn J Cancer Res       Date:  1990-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.